The effects on phosphoinositide metabolism of preincubation of platelets for 90 min with 10 mM-Li+ were studied. Measurements were made of [32P]phosphate-labelled phosphoinositides and of [3H]inositol-labelled inositol mono-, bis-and tris-phosphate (InsP, InsP2 and InsP3). (1) Li+ had no effect on the basal radioactivity in the phosphoinositides or in InsP2 or InsP3, but it caused a 1.8-fold increase in the basal radioactivity in InsP. (2) Li+ caused a 4-, 3-and 2-fold enhanced thrombin-induced accumulation of label in InsP, InsP2 and InsP3 respectively. Although the elevated labelling of InsP2 and InsP3 returned to nearbasal values within 30-60 min, the high labelling ofInsP did not decline over a period of60 min after addition of thrombin to Li+-treated platelets, consistent with inhibition of InsP phosphatase by Li+. The effect of Li+ was not due to a shift in the thrombin dose-response relationship; increasing concentrations of thrombin enhanced the initial rate of production of radiolabelled inositol phosphates, whereas Li+ affected either a secondary production or the rate of their removal. (3) The only observed effect of Li+ on phosphoinositide metabolism was a thrombin-induced decrease (P < 0.05) in labelled phosphatidylinositol 4-phosphate in Li+-treated platelets; this suggests an effect on phospholipase C. (4) Li+ enhanced (P < 0.05) the thrombin-induced increase in labelled lysophosphatidylinositol, suggesting an effect on phospholipase A2. (5) It is concluded that Li+ inhibits InsP phosphatase and has other effects on phosphoinositide metabolism in activated platelets. The observed effects occur too slowly to be the mechanism by which Li+ potentiates agonist-induced platelet activation.
INTRODUCTION
With many types of cells, including platelets, the hydrolysis of phosphoinositides may be a primary event in agonist-induced activation [for reviews, see Berridge (1984) and Nishizuka (1984) ]. Thus agonists cause an accelerated turnover of the phosphoinositides, and some of the products of the phospholipase C-catalysed hydrolysis of phosphoinositides may have secondmessenger roles. For example, diacylglycerol has been shown to activate protein kinase C (Takai et al., 1979) , and InsP3 has been reported to mobilize intracellular Ca2+ in permeabilized cells (Streb et al., 1983) . Either of these, or the combination of the two, could constitute a signal arising from a receptor-linked activation of phosphoinositide turnover.
Li+ causes a decrease in the content of myo-inositol in rat brain (Allison & Stewart, 1971) and an increase in that of InsP (Allison et al., 1976; Sherman et al., 1981) , a consequence of inhibition of InsP phosphatase (Hallcher & Sherman, 1980) . The effects ofLi+ on phosphoinositides are more pronounced after addition of agonists ; Berridge et al. (1982) demonstrated that Li+ could effectively amplify the agonist-induced phosphoinositide response, measured as the accumulation of InsP, of certain tissues. An enhanced agonist-induced accumulation of InsP2 and InsP3 Thomas et al., 1984) suggests that Li+ might also inhibit phosphatases for these intermediates, but with cell-free systems such inhibition is not apparent (Seyfred et al., 1984; Connolly et al., 1985) . The reported enhancement by Li+ of agonist-induced diacylglycerol production (Drummond & Raeburn, 1984 ) cannot be attributed directly to inhibition of a phosphatase, suggesting still more extensive effects of Li+ on agonist-accelerated phosphoinositide metabolism.
If Li+ enhances the agonist-induced accumulation of these intermediates, and if any of the intermediates acts as a second messenger, Li+ might potentiate the responses of cells to agonists. It has, in fact, been reported that prolonged incubation of human platelets in plasma containing added Li+ leads to potentiation of agonistinduced aggregation, secretion andthromboxane synthesis (Imandt et al., 1977 (Imandt et al., , 1980 (Imandt et al., , 1981 .
To gain insight into the role of phosphoinositide metabolism in stimulus-response coupling in platelets, we have examined the effects of Li+ on phosphoinositide metabolism in resting platelets and in platelets activated by thrombin. 
EXPERIMENTAL

Platelet preparation
Platelets were prepared from 200 ml of blood collected into acid/citrate/dextrose (Aster & Jandl, 1964) anticoagulant by venipuncture of healthy donors who had taken no drug during the previous 2-week period. Platelet-rich plasma, obtained by centrifugation of the blood at 300 g for 20 min at room temperature, was centrifuged at 1000 g for 20 min to recover platelets. The platelets were resuspended in 10 ml of modified Ca2+-free Tyrode-Hepes buffer (134 mM-NaCl/12 mM-NaHCO3/ 2.9 mM-KCl/0.34 mM-Na2HPO4/2 mM-MgCl2/5 mMHepes/5 mM-glucose/1 mM-EGTA, adjusted to pH 7.4) containing either [3H]inositol (70 ,uCi/ml) or [32P]P, (50 ,uCi/ml). After incubation for 2 h at 37°C, the platelets were collected by centrifugation (1000 g, for 20 min), washed in 100 ml of the above buffer and finally resuspended in the same buffer but without EGTA and with 0.02 unit of apyrase/ml and 2 mg of albumin/ml (both from Sigma Chemical Co., St. Louis, MO, U.S.A.). This final suspension contained 4 x 108-6 x 108 platelets/ml. For studies of the effects of Li+, platelets were incubated with an additional 10 mM-LiCl or 10 mM-NaCl (control) for 90 min.
Activation of platelets with thrombin
Reactions were at 37°C with 1 ml platelet suspension in a 5 ml cuvette with a 3 mm stirring bar driven by a magnet at 1100 rev./min. (w/v) trichloroacetic acid; the contents of the cuvette were then transferred to a centrifuge tube, and the cuvette was rinsed with 0.5 ml of 5 % trichloroacetic acid, which was also added to the centrifuge tube. After centrifugation for 10 min at 1000 g, the supernatant solution was removed and extracted with 10 ml of diethyl ether to remove trichloroacetic acid. The aqueous phase, containing the inositol phosphates, was adjusted to pH 7.2 and diluted to 5 ml with water before application to an AGi -X8 ion-exchange column for separation of the inositol phosphates as described by Downes & Michell (1981 Downes & Michell (1981) .
Measurement of labelled phosphoinositides
The [32P]phosphate-labelled phosphoinositides were extracted and analysed essentially as described by Billah & Lapetina (1982) . Platelet suspensions (1 ml) were extracted with 3.6 ml of chloroform/methanol/ HCl/100 mM-EDTA (100: 200:2: 3, by vol.). The phases were separated by addition of 1.2 ml of chloroform followed by 1.2 ml of 2 M-KCI. The lower phase (chloroform) was transferred and combined with a 4 ml chloroform wash of the upper phase. These combined chloroform phases were dried under N2, and the lipids were dissolved in 60 ,1 of chloroform. The lipids were separated by t.l.c. on Silica HL plates impregnated with 10% potassium oxalate containing 2 mM-EDTA. The chromatograms were developed with chloroform/ methanol/4 M-NH3 (9:7:2, by vol.). It has been reported that with this chromatographic system an unidentified phospholipid can represent as much as one-third of the total radioactivity in the PtdIns4P spot, but that the amount of the contaminating radioactivity is not affected by activation of the platelets with thrombin (Tysnes et al., 1985) . After location of the lipids by autoradiography, spots were scraped off the plates and counted for radioactivity in 5 ml ofUltrafluor (National Diagnostics). For each time point, triplicate samples of the platelet suspension were extracted and chromatographed; the average of these three measurements was used as a single measurement for the statistical analysis.
RESULTS
Potentiation of platelet activation by Li+
We confirmed the previous reports (Imandt et al., 1977 (Imandt et al., , 1980 ) that addition of 10 mM-Li+ to human citrated platelet-rich plasma for 90 min potentiated platelet aggregation and secretion induced by ADP or the bivalent-cationophore A23 187. The potentiation was slight; it was more obvious at agonist concentrations that gave biphasic aggregation, where just a slightly higher concentration of agonist causes a qualitatively different response. We also observed that Li+ slightly potentiated the response to thrombin of platelets suspended in plasma-free buffered solutions. We were, however, unable to observe consistent potentiation after the prolonged incubations required to prelabel platelets for the measurements of phosphoinositide metabolism.
Thrombin-induced accumulation of [3Hjinositol phosphates
The time courses ofthrombin-induced accumulation of inositol phosphates in human platelets have been measured as mass (Rittenhouse & Sasson, 1985) or as radioactivity (Watson et al., 1984; Siess, 1985) , with somewhat different results; the mass of InsP3 reached a maximum by 15 s and returned to basal values within 2 min, whereas the labelled InsP3 remained elevated after 2 min. Our results with platelets preloaded with labelled inositol, shown in Fig. 1 for three concentrations of thrombin, are similar to the results of other radioactivity measurements (Watson et al., 1984; Siess, 1985 (Hallcher & Sherman, 1980) , we examined the effects of longer incubation with thrombin (Fig. 3) . The experiments were as described for Fig. 1 (Fig. 4) . The thrombin-induced decrease in labelled Ptdlns contrasts with other reports (Holmsen et al., 1981 (Holmsen et al., , 1984 of substantial increases in labelled [32P]Ptdlns 2 min after addition of thrombin. The discrepancy appears to be due to different conditions for loading labelled phosphate. When loading was for 60 min with platelets resuspended in acid/citrate/dextrose-plasma, a widely used condition, we found that only 2% of the phosphoinositide label was in Ptdlns. This indicates little incorporation of label into the diester phosphate, and is consistent with little turnover of phosphoinositides but rapid exchange between ATP and 4-and 5-phosphate groups of PtdIns4P and Ptdlns4,5P2. Under this condition, any enhanced turnover, even if accompanied by a decrease in mass, would lead to an increase in total radioactivity in Ptdlns. When the loading was in a plasma-free solution (as for this study), however, the total radioactivity in phosphoinositides was 5-8-fold greater, and 16-29% of the phosphoinositide label was in Ptdlns, indicating substantial labelling of the diester phosphate. After further incubation for 90 min (with or without Li+), there was little change in total radioactivity in phosphoinositides or in the proportions of label in Ptdlns:PtdIns4P: Ptdlns4,5P2 (approx. 1:1:1), which remained considerably higher than most published results (see comparisons by Tysnes et al., 1985) . (In contrast, when platelets were loaded in plasma, a subsequent incubation in a plasma-free solution for 90 min led to a substantial increase in label in Ptdlns). Since our 90 min incubation after loading presumably also would lead to a lower specific radioactivity of ATP, a thrombin-induced increase in specific radioactivity of Ptdlns would not occur; instead our results are more similar to those from measurements of mass (Broekman et al., 1980; Bell & Majerus, 1980) . At 10 mm, Li+ had no effect on the time courses of thrombin-induced changes in labelled Ptdlns or Ptdlns4,5P2 (Fig. 4) We also observed that Li+ caused a greater thrombininduced production oflabelled lyso-Ptdlns (Fig. 5) , which presumably arises from the action of phospholipase A2 . This is consistent with the enh?pAced thromboxane production in Li+-treated platelets reported previously by Imandt et al. (1981) , DISCUSSION We were interested in two reported effects of Li+. It has been reported to enhance agonist-induced accumulation of inositol phosphates in some cells (Berridge et al., 1982; Thomas et al., 1984) , and it has been reported to potentiate the response of human Vol. 236 Ptdlns4,5P, PtdIns4P and Ptdlns in the absence (@) or presence (0) of 10 mM-LiCl [32P]Phosphate-labelled platelets were incubated at 37°C for 90 min after addition of 10 mM-NaCl (control, 0) or 10 mM-LiCl (0). After addition of 15 nM-thrombin, labelled phospholipids were extracted and analysed at the indicated times as described in the Experimental section. The results (means+S.E.M. for five separate experiments, each with triplicate measurements) are expressed as a percentage of the basal (before thrombin) radioactivity. The differences between control and Li+-treated platelets at 30 and 120 s for PtdIns4P are statistically significant (P < 0.05). The basal values (c.p.m./106 platelets) for PtdIns4,5P2, PtdIns4P and Ptdlns were 21074+7612, 21351+7359 and 27088 + 9736 for control platelets and 21575+4298, 21699+4253 and 27119+7292 for Li+-treated platelets. platelets to agonists (Imandt et al., 1977 (Imandt et al., , 1980 (Imandt et al., , 1981 . If an inositol phosphate is a second messenger, the mechanism of potentiation by Li+ might involve an increase in the concentration of the inositol phosphate either before the agonist or as a consequence of the agonist. We reasoned that potentiation by Li+ could therefore involve a defined mechanism for studies of synergism and potentiation of platelet agonists. This is clearly not the case. Although inhibition of InsP phosphatase is obvious, as predicted from published work with other cells, other effects on phosphoinositide metabolism are also apparent, and there is reason to question whether effects on phosphoinositide metabolism are in fact the mechanism of potentiation by Li+. We chose to analyse phosphoinositide metabolites by incorporation of radioactive precursors, because direct measurements of mass require large amounts of very concentrated platelet suspensions and do not reveal changes in small, metabolically active, pools or changes in rates of turnover. Measurements of radioactivity are sufficiently sensitive, but they require cautious interpretation. It is unlikely that platelets have a homogeneous pool of phosphoinositides, and an increased rate of turnover of a metabolite will result in either an increase or a decrease in radioactivity, depending on whether the precursor has a higher or lower specific radioactivity. We therefore restrict our interpretation to comparisons between control and Li+-treated platelets.
The inhibition by Li+ of InsP phosphatase in intact human platelets is apparent from the large thrombininduced accumulation of labelled InsP without a subsequent decline after other labelled inositol phosphates had returned to near-basal radioactivity values (Fig. 3) . Other effects of Li+ on thrombin-activated phosphoinositide metabolism were apparent as an enhanced accumulation of labelled InsP2 and InsP3 (Figs. 2 and 3) , as a thrombin-induced decrease in labelled PtdIns4P (Fig.  4) and as an enhanced thrombin-induced accumulation of labelled lyso-Ptdlns (Fig. 5) . Although accumulation of labelled InsP2 and InsP3 could indicate inhibition of their phosphatases, it could be only a slight inhibition, because return to basal values occurred at the same rates (half-times) in control and Li+-treated platelets. Other explanations are also plausible. For example, the observation that Li+ caused a thrombin-induced depletion of labelled PtdIns4P indicates that at least part of the enhanced accumulation oflabelled InsP2 could have been due to more rapid production, consistent with the observation by Drummond & Raeburn (1984) that Li+ caused enhanced agonist-induced production of diacylglycerol in GH3 pituitary cells. Our measurements of diacylglycerol accumulation in thrombin-activated platelets were, unfortunately, inconclusive, and we cannot estimate the extent to which an increased rate of hydrolysis could account for the greater, transient, accumulation oflabelled InsP2 . The enhanced production of labelled lyso-Ptdlns indicates that Li+ also had some effect unrelated to either production or degradation of inositol phosphates.
In similar experiments with rabbit platelets, Vickers et al. (1984) observed a 3-6-fold greater accumulation of labelled InsP3 30-120 s after addition of thrombin, with a 2-fold greater accumulation of labelled InsP2 at the 120 s time point only. In contrast with our observations, they found Li+ effects at the earliest time points after addition of the agonist, and they found no effect consistent with inhibition of InsP phosphatase. The failure to see inhibition of InsP phosphatase was probably because they measured intermediates for only 2 min after addition ofthrombin, whereas the effect ofLi+ is not apparent until later (Fig. 3) . Watson et al. (1984) observed little effect of Li+ on [3H]inositol-labelled InsP2 or InsP3 for 2 min after addition of thrombin to washed human platelets, but their observed effect of Li+ on the thrombin-induced increase in InsP was greater than we report here. Since their data for control and Li+-treated platelets were from separate experiments, exact quantitative comparisons are, however, difficult. Siess (1985) reported that incubation of human platelets with Li+ caused an increase in labelled Ins4P as well as InsIP; Li+ enhanced the thrombin-induced accumulation of label in InsIP, and the vasopressin-induced increases in both InsIP and Ins4P.
We conclude that our data, together with published data for other cell systems, indicate that in intact human platelets Li+ inhibits InsP phosphatase, but that there are, in addition, other effects on thrombin-induced phosphoinositide metabolism. It is impossible to deduce from these data which were primary and which were secondary effects of Li+.
Some of the effects of Li+ that we report here have certain characteristics essential for an event that causes potentiation. It is apparent that the enhanced thrombininduced accumulation of labelled inositol phosphates in Li+-treated platelets was not simply a reflection of greater sensitivity to thrombin, because the effect was a qualitative change rather than a shift in a dose-response curve (Fig. 2) . rhus an enhanced accumulation of a postulated second messenger appears to be a primary effect. It does not, however, appear to be the cause of potentiation. Since the extent of thrombin-induced platelet activation is determined quickly, any cause of an enhanced response to thrombin should also occur quickly, but the effect of Li+ on thrombin-induced phosphoinositide metabolism was not apparent until 30 s after addition of thrombin. It may, however, be significant that the potentiation by Li+ of platelet aggregation and secretion that we observe tends to be greater at later times (> 30 s), consistent with most of the potentiation described by Imandt et al. (1977 Imandt et al. ( , 1980 . A major difficulty in assessing the possible role of phosphoinisotide metabolism in potentiation by Li+ is that there appears to be no simple correlation of amount of postulated second messenger with extent of response (see, e.g., Thomas et al., 1984) . Thus, if InsP3 is a second messenger, the effect of Li+ on its accumulation in response to thrombin would be comparable to at least doubling the concentration of thrombin, but such a great effect on platelet responses is never observed. This may indicate that the effect on phosphoinositide metabolism is not the mechanism of potentiation, or it may only reveal a lack of direct proportionality of concentration of InsP3 and extent of activation, perhaps because only one of the measured InsP3 isomers is active (Irvine et al., 1984) , as suggested by Burgess et al. (1985) .
